作者
Gianluca Gortan Cappellari,Christelle Guillet,Eleonora Poggiogalle,María D. Ballesteros-Pomar,John A. Batsis,Yves Boirie,I. Bretón,Stefano Frara,Laurence Genton,Yftach Gepner,Maria Cristina Gonzalez,Steven B. Heymsfield,Eva Kiesswetter,Alessandro Laviano,Carla M. Prado,Ferruccio Santini,Mireille J. Serlie,Mario Siervo,Dennis T. Villareal,Dorothee Volkert,Trudy Voortman,P.J.M. Weijs,Mauro Zamboni,Stephan C. Bischoff,Luca Busetto,Tommy Cederholm,Rocco Barazzoni,Lorenzo Maria Donini,Anja Bosy‐Westphal,Amelia Brunani,Paolo Capodaglio,Dario Coletti,Elisabetta Ferretti,Francesco Frigerio,Andrea Giustina,Andrea Lenzi,Elisabetta Marini,Silvia Migliaccio,Marianna Minnetti,Edoardo Mocini,Tatiana Moro,Maurizio Muscaritoli,Philippe Noirez,Antonio Paoli,Mariangela Rondanelli,Auralia Rughetti,Josje D. Schoufour,Anna Skalska,Eva Topinková,Hidekata Wakabayashi,Jianchun Yu
摘要
The European Society for Clinical Nutrition and Metabolism (ESPEN) and the European Association for the Study of Obesity (EASO) launched the Sarcopenic Obesity Global Leadership Initiative (SOGLI) to reach expert consensus on a definition and diagnostic criteria for Sarcopenic Obesity (SO). The present paper describes the proceeding of the Sarcopenic Obesity Global Leadership Initiative (SOGLI) meeting that was held on November 25th and 26th, 2022 in Rome, Italy. This consortium involved the participation of 50 researchers from different geographic regions and countries. The document outlines an agenda advocated by the SOGLI expert panel regarding the pathophysiology, screening, diagnosis, staging and treatment of SO that needs to be prioritized for future research in the field.